Medxy AI

Randomized Quality Improvement Trials: Enhancing Healthcare Safety with Ethical Oversight

By MedXY 08/24/2026

Randomized Quality Improvement (RQI) trials offer robust evidence for healthcare interventions but raise ethical and regulatory challenges. A proposed framework provides streamlined oversight enabling safer, evidence-based care improvements within health systems.

Hematology-Oncology news

ATG Versus ATG Plus Post-Transplant Cyclophosphamide: A Pilot Trial for GvHD Prophylaxis in Matched Donor Hematopoietic Cell Transplants

By MedXY 08/24/2026

A randomized pilot trial shows comparable survival and safety outcomes for anti-thymocyte globulin alone versus combined with post-transplant cyclophosphamide, supporting further phase III investigation for graft-versus-host disease prophylaxis in matched donor hematopoietic cell transplantation.

Clinical Updates Hematology-Oncology news

Response Kinetics Following CAR T-Cell Therapy for Large B-Cell Lymphoma: Insights from the LYSA DESCAR-T Registry

By MedXY 08/24/2026

This review synthesizes real-world data from the DESCAR-T registry on CAR T-cell therapy response kinetics in large B-cell lymphoma, highlighting the prognostic impact of early response patterns and factors influencing conversion from partial to complete remission.

Hematology-Oncology news

Decoding ATRA Resistance in Acute Promyelocytic Leukemia: The Role of PML::RARA Mutations Enhancing Basal Repression

By MedXY 08/24/2026

A clustered subset of hotspot PML::RARA mutations drives ATRA resistance in acute promyelocytic leukemia by enhancing basal transcriptional repression rather than disrupting transactivation, suggesting novel mechanisms underlying therapeutic failures.

$Enhanced Salvage Therapy in Relapsed/Refractory AML: Venetoclax Plus High-Dose Cytarabine and Mitoxantrone Shows Promising Outcomes and Risk Stratification Insights$

Hematology-Oncology news Oncology

Enhanced Salvage Therapy in Relapsed/Refractory AML: Venetoclax Plus High-Dose Cytarabine and Mitoxantrone Shows Promising Outcomes and Risk Stratification Insights

By MedXY 08/24/2026

A multicenter real-world study demonstrates that combining venetoclax with high-dose cytarabine and mitoxantrone significantly improves remission and survival rates in relapsed/refractory AML, with validated risk factors guiding prognostication.

Hematology-Oncology news

Transcription Factor NFE2: A Crucial Regulator of Redox Balance and Chemotherapy Resistance in Acute Myeloid Leukemia

By MedXY 08/24/2026

NFE2 drives leukemic transformation through redox regulation, modulating glutathione homeostasis and detoxification pathways, and confers chemotherapy resistance in AML. Targeting NFE2 may enhance therapeutic efficacy and improve patient outcomes.

Hematology-Oncology news Oncology

Oncogenic DHX15 Mutation Drives Mitochondrial Metabolism to Sustain Leukemia Stemness in AML

By MedXY 08/24/2026

A hotspot DHX15R222G mutation collaborates with AML1-ETO fusion to enhance mitochondrial function and leukemia stem cell activity, leading to poorer prognosis and chemotherapy resistance in AML, unveiling OXPHOS inhibition as a promising targeted therapy.

Hematology-Oncology news

Sustained Genetic Silencing of BCL11A Using shmiR Vector in Sickle Cell Disease: Long-Term Safety and Efficacy

By MedXY 08/24/2026

This article reviews the first-in-human study demonstrating durable and safe posttranscriptional silencing of BCL11A in sickle cell disease patients using a shmiR vector, resulting in stable fetal hemoglobin induction and clinical benefit over 4+ years.

Cardiology news Respiratory

Linking Pulmonary and Cardiac Health: Centrilobular Emphysema as a Predictor of Coronary Artery Calcification Progression

By MedXY 08/24/2026

Long-term data from lung cancer screening reveal centrilobular emphysema progression strongly associates with coronary artery calcification worsening, highlighting systemic vascular implications of this emphysema subtype.

news Radiology Respiratory

Incidental Emphysema Detected on Routine Screening Chest CT and Its Association with Mortality in a Korean Population

By MedXY 08/24/2026

This study evaluates the independent association between incidental emphysema found on routine screening chest CT scans and all-cause mortality in a large Korean cohort, highlighting implications for risk stratification among ever-smokers.

news Ophthalmology Pediatrics

Long-Term Outcomes of Strabismus Surgery in Children with Perinatal Brain Injury: Insights and Clinical Implications

By MedXY 08/24/2026

Children with perinatal brain injury exhibit lower long-term success rates following strabismus surgery, mainly due to undercorrection despite comparable surgical dosing. Larger preoperative deviations predict poorer outcomes, underscoring the need for tailored counseling and treatment strategies.

news Ophthalmology

Novel Peripheral Retinal Vascular Biomarker on Ultra-Widefield OCTA Enables Severity Grading in Retinitis Pigmentosa

By MedXY 08/24/2026

Ultra-widefield OCT angiography identifies distinct peripheral retinal vascular phenotypes and a quantitative CNZ biomarker, facilitating an objective four-stage grading system for retinitis pigmentosa severity assessment and clinical trial stratification.

news Ophthalmology

Impact of Trabeculectomy versus Medical Therapy on Visual Field and Quality of Life in Advanced Glaucoma: Insights from the TAGS Study

By MedXY 08/24/2026

The TAGS Study shows trabeculectomy slows visual field loss more effectively than medical treatment in advanced glaucoma, yet this did not translate into significant quality-of-life improvements over five years, highlighting limitations in current patient-reported outcome measures.

news Oncology Otorhinolaryngology

Enhanced Pathologic Responses with Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma

By MedXY 08/24/2026

Neoadjuvant chemoimmunotherapy significantly improves pathologic complete and major responses compared to immunotherapy alone in resectable head and neck squamous cell carcinoma, suggesting a promising avenue to improve treatment outcomes.

General Surgery news Otorhinolaryngology

Post-Bariatric Surgery Patulous Eustachian Tube: Weight Loss Velocity as a Predictor of Chronicity

By MedXY 08/24/2026

Weight loss velocity, rather than absolute weight loss, predicts the onset and persistence of Patulous Eustachian Tube symptoms after bariatric surgery, highlighting the need for close monitoring during rapid BMI decline phases.

Clinical Updates news Oncology Otorhinolaryngology

Impact of Neighborhood Socioeconomic Deprivation on Breslow Thickness and Clinical Outcomes in Head and Neck Cutaneous Melanoma: A Comprehensive Review

By MedXY 08/24/2026

This review synthesizes evidence linking neighborhood socioeconomic deprivation with increased Breslow thickness and delayed surgical management in head and neck cutaneous melanoma, highlighting potential mechanisms and clinical implications.

Diabetes & Endocrinology General Surgery news

Risk Factors and Management of Iatrogenic Hypercalcemia during Active Vitamin D Supplementation for Hypoparathyroidism Post-Total Thyroidectomy

By MedXY 08/24/2026

Iatrogenic hypercalcemia complicates 14% of hypoparathyroidism cases post-total thyroidectomy, linked to low early postoperative parathyroid hormone and early vitamin D initiation. Careful supplementation and monitoring are vital in preventing severe outcomes.

General Surgery news Psychiatry

Spiritual Distress Before Elective Surgery: Understanding Its Impact on Patient Experience and Outcomes

By MedXY 08/24/2026

This qualitative study reveals how spiritual distress shapes patients' fears and hopes before elective surgery, emphasizing the need for routine spiritual well-being assessment to support resilience and improve perioperative care.

Cardiology Diabetes & Endocrinology news

Parathyroidectomy Significantly Lowers Cardiovascular Risk in Primary Hyperparathyroidism: Insights from a Population-Wide Target Trial Emulation

By MedXY 08/24/2026

This population-wide study demonstrates that parathyroidectomy in primary hyperparathyroidism reduces major adverse cardiovascular events risk, particularly in patients with higher serum calcium levels.